Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$212.15 USD

212.15
651,165

+1.37 (0.65%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $211.69 -0.46 (-0.22%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite

QIAGEN N.V. (QGEN) recently announced the acquisition of Cary, NC-based OmicSoft Corporation.

    LLabCorp: Reimbursement Scenario a Drag Amid Other Woes

    On Jan 09, we issued an updated research report on Burlington, NC-based Laboratory Corporation of America Holdings (LH) or LabCorp.

      ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders

      ResMed Inc. (RMD) recently formed a joint venture with renowned surgeon and television host Dr. Mehmet Oz and private equity firm Pegasus Capital Advisors, L.P.

        Myriad Genetics: Evidence Street Reviews EndoPredict Test

        Myriad Genetics, Inc. (MYGN) recently announced that Blue Cross Blue Shield Association's technical assessment provider Evidence Street has reviewed its EndoPredict assay.

          Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View

          Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of $1.10 in first-quarter fiscal 2017, up 6.8% from the year-ago quarter.

            Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite

            Bruker Corporation (BRKR) recently announced the buyout of Hennigsdorf, Germany-based InVivo Biotech Services GmbH.

              Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging

              Bruker Corporation (BRKR) recently announced the acquisition of Bremen, Germany-based software solutions developer, SCiLS GmbH.

                ResMed Achieves Key Milestone in Sleep-Disordered Breathing

                After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea.

                  Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay

                  Hologic, Inc. (HOLX) recently announced the receipt of the FDAs Premarket Approval (PMA) for its Aptima HIV-1 Quant assay.

                    IDEXX Laboratories (IDXX) Set to Join the S&P 500 Index

                    IDEXX Laboratories, Inc. (IDXX) is scheduled to join the coveted S&P 500 benchmark, after the market closes on Jan 4.

                      Illumina Fettered With Losses: Can It Bounce Back in 2017?

                      During majority of the past one year, Illumina (ILMN) lagged the Zacks classified broader Medical - Biomedical and Genetics industry.

                        Masimo to Launch Advanced Monitoring Technologies in India

                        Masimo (MASI) announced that it will launch Advanced Monitoring Technologies in the Indian market.

                          OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3

                          OPKO Health Inc. (OPK) announced failure in its data analysis of the Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults.

                            Abaxis (ABAX) Veterinary Prospects Bright: Should You Hold?

                            On Jan 2, 2017, Abaxis Inc. (ABAX), a leading manufacturer of portable medical and veterinary blood analysis systems, was upgraded to a Zacks Rank #3 (Hold).

                              Is Baxter Poised to Counter Low Cyclophosphamide Sales?

                              On Dec 30, we issued an updated research report on Deerfield, IL-based Baxter International Inc. (BAX), a global medical technology company and leading provider of renal and hospital products.

                                CryoLife (CRY) Now a Strong Buy on Solid Estimate Revisions

                                On Dec 27, CryoLife Inc. (CRY) was upgraded to a Zacks Rank #1 (Strong Buy).

                                  Alere (ALR) Appeals to Reinstate Medicare Billing Privilege

                                  Alere Inc. (ALR) announced that it has recently appealed at the Centers for Medicare & Medicaid Services for reinstatement of Medicare billing privilege.

                                    NuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite

                                    NuVasive (NUVA) recently announced the receipt of approval from MHLW, for instruments used in the eXtreme Lateral Interbody Fusion (XLIF) procedure.

                                      LabCorp: Covance Drug Prospects Bright, Competition Rife

                                      On Dec 28, we issued an updated research report on Burlington, NC-based Laboratory Corporation of America Holdings (LH).

                                        ResMed: SDB Business Faces Risks, Reimbursement a Drag

                                        On Dec 27, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).

                                          Nutrisystem Declares Multi-Brand Marketing Approach for '17

                                          Nutrisystem Inc. (NTRI) announced that it will focus on a multi-brand marketing approach with two new distinct programs.

                                            What's in Store for Walgreens Boots (WBA) in Q1 Earnings?

                                            Walgreens Boots Alliance, Inc (WBA) is slated to release first-quarter 2017 results, before the market opens on Jan 5.

                                              Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger

                                              On Dec 27, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).

                                                Align Technology Hits 52-Week High on Q3 & Dental Strength

                                                Share price of San Jose, CA-based Align Technology, Inc. (ALGN) scaled a new 52-week high of $102.1 on Dec 19, finally closing a bit lower at $100.3.

                                                  Align Up on Balanced Growth, Expansion of Invisalign Teen

                                                  On Dec 9, 2016, we issued an updated research report on California-based Align Technology Inc. (ALGN).